Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease | Clinical Trial - SIGNIFY

Description:

The goal of the trial was to evaluate treatment with ivabradine compared with placebo among patients with stable coronary artery disease without clinical heart failure.